Table 1.
Methods | Modifications Detected | Quantification | Genome Wide | Positional Information | Remarks (Pros/Cons) | ||
---|---|---|---|---|---|---|---|
Structure Determination | X-ray Cristallography | All modifications | ✕ / ✓ | ✕ | ✓ | Difficult to obtain crystals | |
Cryo Electron Microscopy | Heterogeneous resolution | ||||||
Nuclear Magnetic Resonance | Size limit | ||||||
LC/MSMS | Nucleoside analysis | DMRM [34] | Known modifications | ✓ | ✓ | ✕ | Fragmentation pattern and retention time of modifications must be known |
NLS [34] | Various modifications | ✓ | ✓ | ✕ | NLS is less suitable for quantification than DMRM | ||
Fragment analysis | With a reference (SILNAS/CARD/ SILCARD) [52,53] |
Known modifications | ✓ | ✕ | ✓ | Relative quantification can be assessed with reference in vitro RNA | |
Without reference (RNase digests) [39] | Known modifications | ✕ | ✕ | ✓ | Determination of base composition and localization by comparing mass-spectrometry results with expected RNase fragments | ||
NGS-based methods | RNA deep-sequencing direct method | A-to-I [54] | ✓ | ✓ | ✓ | To be accompanied by DNA sequencing to distinguish editing events from SNPs | |
Methylations [55] | ✕ | ✕ | Based on RT stops or misincorporations | ||||
Nanopore RNA sequencing [56,57] | m6A, m5C, A-to-I, Ψ and others | ✓ | ✓ | Based on the use of systematic base-calling ‘errors’ caused by the presence of RNA modifications. Software is still in development | |||
Indirect methods: chemical treatments | ICE-Seq [58,59] | A-to-I | ✓ | ✓ | No need of DNA seq | ||
Bisulfite-Seq [60] | m5C | ||||||
Riboxi-Seq [61] | Nm | ||||||
RiboMethSeq [62,63] | |||||||
Pseudo-Seq [64] | Ψ | ||||||
Ψ-Seq | |||||||
PSI-Seq [65] | |||||||
HydraPsi-Seq [66] | |||||||
SLAM-Seq [67] | s4U | ||||||
ARM-Seq [68] | m1A, m3C, m1G | ||||||
TRAC-Seq [69] | m7G | ||||||
AlkAniline-Seq [70] | m7G, m3C, D | ||||||
Indirect methods: IP | miCLIP [71] | Methylation | ✓ | ✓ | |||
m6A-Seq [72] | m6A | ||||||
meRIP-Seq [73] | |||||||
m6A-LAIC-Seq [74] | |||||||
Nm-Seq / 2OMe-Seq [75] | Nm | ||||||
acRIP-Seq [76] | ac4C | ||||||
NAD capture-Seq [77] | 5’-NAD cap | ||||||
Affinity gel electrophoresis | Mercury-sulfur affinity [78] | s2U, s4U | ✕ | ✕ | ✕ | APM treatment (Acrylo-aminophenylmercuric chloride) | |
Boronate affinity [79] | NAD- or FAD-modified RNAs | ✓ | ✓ | ✕ | APB treatment (Acryloylaminophenyl boronic acid); fast screening (easy and quick); quantification possible as per intensity of bands |
✕ = not available; ✓ = available.